Disease-modifying therapies (DMTs) discontinuation in older relapsing-remitting multiple sclerosis (RRMS) patients with stable disease: Two-year randomized, controlled trial.

Daneshyar S, Ghiasian M, Khazaei S, Alborzi K, Ebadi M

Caspian J Intern Med. 2026; 17(3):589-594. PMID: 42924257. Abstract